Drugs / Fast Dual CAR-T Injection
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04877080 | May 2021 → Jun 2023 | B-cell non-Hodgkin lymphoma | 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fast Dual CAR-T Injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04877080 ↗ |
| Modality | Cell therapy | “autologous dual chimeric antigen receptor T-cell (CAR-T) therapy” NCT04877080 ↗ |
| Route | Intravenous | “administered intravenously” NCT04877080 ↗ |